Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| β3 adrenergic receptor activation modulates connexin 43 activity to relax human myometrium. | Cell Signal | 2023 | 36841274 | PubTator, text mining | PubMed |
| Formulation Approaches to Crystalline Status Modification for Carotenoids: Impacts on Dissolution, Stability, Bioavailability, and Bioactivities. | Pharmaceutics | 2023 | 36839810 | PubTator, text mining | PubMed |
| Pre- versus Post-Menopausal Onset of Overactive Bladder and the Response to Vaginal Estrogen Therapy: A Prospective Study. | Medicina (Kaunas) | 2023 | 36837446 | PubTator, text mining | PubMed |
| Effect of PACAP on Heat Exposure. | Int J Mol Sci | 2023 | 36835411 | PubTator, text mining | PubMed |
| The ABA/LANCL1/2 Hormone/Receptor System Controls Adipocyte Browning and Energy Expenditure. | Int J Mol Sci | 2023 | 36834900 | PubTator, text mining | PubMed |
| Alpha1A- and Beta3-Adrenoceptors Interplay in Adipose Multipotent Mesenchymal Stromal Cells: A Novel Mechanism of Obesity-Driven Hypertension. | Cells | 2023 | 36831252 | PubTator, text mining | PubMed |
| GPCR in Adipose Tissue Function-Focus on Lipolysis. | Biomedicines | 2023 | 36831123 | PubTator, text mining | PubMed |
| Association of Epicardial Adipose Tissue Adipocytes Hypertrophy with Biomarkers of Low-Grade Inflammation and Extracellular Matrix Remodeling in Patients with Coronary Artery Disease. | Biomedicines | 2023 | 36830779 | PubTator, text mining | PubMed |
| Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder-Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes. | Toxins (Basel) | 2023 | 36828410 | PubTator, text mining | PubMed |
| The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies. | Aging Dis | 2023 | 36818566 | PubTator, text mining | PubMed |
| Stimulation of the beta-2-adrenergic receptor with salbutamol activates human brown adipose tissue. | Cell Rep Med | 2023 | 36812890 | PubTator, text mining | PubMed |
| Protein kinase D1 (Prkd1) deletion in brown adipose tissue leads to altered myogenic gene expression after cold exposure, while thermogenesis remains intact. | Physiol Rep | 2023 | 36807778 | PubTator, text mining | PubMed |
| Thermogenic Brown Fat in Humans: Implications in Energy Homeostasis, Obesity and Metabolic Disorders. | World J Mens Health | 2023 | 36792089 | PubTator, text mining | PubMed |
| LGR4: A New Receptor Member in Endocrine and Metabolic Diseases. | Endocr Rev | 2023 | 36791020 | PubTator, text mining | PubMed |
| FABP4 Expression in Subcutaneous Adipose Tissue Is Independently Associated with Circulating Triglycerides in Obesity. | J Clin Med | 2023 | 36769659 | PubTator, text mining | PubMed |
| Management of Obesity and Obesity-Related Disorders: From Stem Cells and Epigenetics to Its Treatment. | Int J Mol Sci | 2023 | 36768633 | PubTator, text mining | PubMed |
| Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target. | Int J Mol Sci | 2023 | 36768561 | PubTator, text mining | PubMed |
| Profiling of G-Protein Coupled Receptors in Adipose Tissue and Differentiating Adipocytes Offers a Translational Resource for Obesity/Metabolic Research. | Cells | 2023 | 36766718 | PubTator, text mining | PubMed |
| An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis. | Cancers (Basel) | 2023 | 36765694 | PubTator, text mining | PubMed |
| Mixed urinary incontinence: Are there effective treatments? | Neurourol Urodyn | 2023 | 36762411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=21